Joyce Yi-Frazier, PhD
Principal Scientist, Dana-Farber
Serious and chronic illnesses impose a significant psychosocial burden on patients, caregivers, and healthcare providers. Adolescents and young adults (AYAs) with conditions such as cancer, diabetes, or cystic fibrosis face unique challenges. These include navigating the complexities of illness while managing the developmental milestones of adolescence and early adulthood. This dual burden often leads to higher risks of poor mental health outcomes, including anxiety, depression, and reduced quality of life. Even after recovery, survivors of serious illnesses frequently experience long-term psychosocial challenges, while those with chronic conditions struggle with adherence to treatment plans and self-management.
Caregivers and healthcare workers are not immune to these stressors. Caregivers often experience burnout and emotional exhaustion, while healthcare providers face elevated risks of stress, anxiety, and professional burnout. These challenges highlight the urgent need for scalable, accessible, and evidence-based interventions to address the mental health crisis in individuals with stress-related illnesses.
Traditional mental health interventions, such as cognitive behavioral therapy (CBT), are often resource-intensive and lack the flexibility to meet the diverse needs of individuals facing acute or chronic stress. Recognizing this gap, Abby Rosenberg, MD, MS, MA, Chief, Pediatrics Palliative Care at Dana-Farber and Joyce Yi-Frazier, PhD, Principal Scientist at Dana-Farber developed the Promoting Resilience in Stress Management (PRISM) program. PRISM is a proactive, skills-based intervention designed to build resilience and improve psychosocial outcomes in individuals experiencing stress related to serious illness.
PRISM is an innovative resilience coaching program that combines evidence-based psychological skills with a flexible delivery model. It is designed to teach participants practical tools to manage stress, improve mental health outcomes, and enhance overall quality of life. The program is tailored to meet the needs of adolescents and young adults with serious illnesses, their caregivers, and healthcare providers, but its applications extend to other high-stress populations as well.
Core Components of PRISM
PRISM has been rigorously tested in over a decade of research, including randomized controlled trials and cohort studies. More than 500 individuals have participated in randomized trials, with hundreds involved in other studies. PRISM has been implemented in diverse settings around the world, including:
The program has consistently demonstrated its ability to improve psychosocial outcomes across diverse populations:
PRISM represents a transformative approach to addressing the psychosocial challenges associated with serious illness by consistently improving resilience, hope, and self-efficacy—key psychological skills that enable individuals to navigate stress and maintain a sense of control over their lives. The program has demonstrated its ability to reduce symptoms of anxiety and depression, enhance quality of life, and mitigate the long-term psychosocial impacts of serious illness across diverse populations. With its evidence-based design, customizable delivery, and digital tools, PRISM is uniquely positioned to meet the growing demand for accessible, scalable mental health interventions.
Team Members: Joyce Yi-Frazier, PhD, Abby Rosenberg, MD, MS, MA, Courtney Junkins, PsyD
PRISM’s flexible, evidence-based design makes it a versatile tool for addressing psychosocial stress in a variety of settings and populations. Its applications include:
PRISM is available for licensing to collaborations interested in:
Principal Scientist, Dana-Farber
Chief of Pediatrics Palliative Care at Dana-Farber
Lead Scientist & Associate Director for Intervention Science, Department of Psychosocial Oncology and Palliative Care